Literature DB >> 16949384

Endogenous estradiol and its association with estrogen receptor gene polymorphisms.

MaryFran R Sowers1, Mary L Jannausch, Daniel S McConnell, Sharon R Kardia, John F Randolph.   

Abstract

We evaluated potential associations between single nucleotide polymorphism (SNP) variants of the estrogen receptor genes ESR1 and ESR2 and circulating estradiol (E2) concentrations in women of 4 races/ethnicities. The study population was drawn from participants in the Study of Women's Health Across the Nation (SWAN). A total of 1,538 African American, Caucasian, Chinese, and Japanese women from SWAN participated in the Sex Steroid Hormone Genetics Protocol by providing blood for sex steroid hormone analyses and consenting to lymphocyte transformation from which DNA was extracted and genotyped. We evaluated 4 ESR1 SNPs (ESR1 rs9340799, ESR1 rs2234693, ESR1 rs728524, and ESR1 rs3798577), and 3 ESR2 SNPs (ESR2 rs1255998, ESR2 rs1256030, and ESR2 rs1256065). Mean E2 level was 196.0 +/- 4.0 pmol/L in women who were premenopausal and perimenopausal (with blood drawn on days 2 through 5 of the menstrual cycle follicular phase); however, mean E2 levels in Chinese and Japanese women were lower (155.7 +/- 10.6 pmol/L and 170.0 +/- 10.3 pmol/L, respectively) than in African American (196.4 +/- 8.1 pmol/L, P <0.05) or Caucasian women (210.7 +/- 5.9 pmol/L, P <0.002). The ESR1 rs3798577 CC genotype was associated with lower circulating E2 concentrations in African American women (P <0.07) and explained about 1% of the variation in circulating E2 concentrations. In Japanese women, the GC genotype of ESR2 rs1255998 was associated with significantly lower circulating E2 concentrations that explained about 4% of the variation. Circulating E2 concentrations were not strongly or consistently associated with selected polymorphisms for the estrogen receptor genes. The 2 strongest associations explained <4% of the total variation in the circulating E2 concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949384     DOI: 10.1016/j.amjmed.2006.07.002

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.

Authors:  Virginia M Miller; Tanya M Petterson; Elysia N Jeavons; Abhinita S Lnu; David N Rider; John A Heit; Julie M Cunningham; Gordon S Huggins; Howard N Hodis; Matthew J Budoff; Nanette Santoro; Paul N Hopkins; Rogerio A Lobo; JoAnn E Manson; Frederick Naftolin; Hugh S Taylor; S Mitchell Harman; Mariza de Andrade
Journal:  Physiol Genomics       Date:  2012-11-27       Impact factor: 3.107

2.  Association of estrogen receptor β gene polymorphisms with vascular dementia in women.

Authors:  Jiawei Xin; Junjian Zhang; Yongzhe Gao; Li Xiong
Journal:  Neurol Sci       Date:  2011-12-20       Impact factor: 3.307

3.  Contribution of polymorphisms in ESR1, ESR2, FSHR, CYP19A1, SHBG, and NRIP1 genes to migraine susceptibility in Turkish population.

Authors:  Salih CoŞkun; Yavuz Yůcel; Abdullah Çim; Beyhan Cengiz; Serdar Oztuzcu; Sefer Varol; Hasan H Özdemir; ErtuĞrul Uzar
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

4.  Oestrogen receptor polymorphisms and late-life depression.

Authors:  Joanne Ryan; Jacqueline Scali; Isabelle Carrière; Karine Peres; Olivier Rouaud; Pierre-Yves Scarabin; Karen Ritchie; Marie-Laure Ancelin
Journal:  Br J Psychiatry       Date:  2011-08       Impact factor: 9.319

5.  Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Authors:  Kerryn W Reding; Chu Chen; Kimberly Lowe; David R Doody; Christopher S Carlson; Christina T Chen; John Houck; Linda K Weiss; Polly A Marchbanks; Leslie Bernstein; Robert Spirtas; Jill A McDonald; Brian L Strom; Ronald T Burkman; Michael S Simon; Jonathan M Liff; Janet R Daling; Kathleen E Malone
Journal:  Cancer Causes Control       Date:  2012-03-15       Impact factor: 2.506

Review 6.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

7.  Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Authors:  V M Miller; D M Black; E A Brinton; M J Budoff; M I Cedars; H N Hodis; R A Lobo; J E Manson; G R Merriam; F Naftolin; N Santoro; H S Taylor; S M Harman
Journal:  J Cardiovasc Transl Res       Date:  2009-05-22       Impact factor: 4.132

8.  Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up.

Authors:  Virginia M Miller; Joann E Manson
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06-01

9.  Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels.

Authors:  Inga Peter; Alyson Kelley-Hedgepeth; Caroline S Fox; L Adrienne Cupples; Gordon S Huggins; David E Housman; Richard H Karas; Michael E Mendelsohn; Daniel Levy; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

10.  Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men.

Authors:  Anna L Eriksson; Mattias Lorentzon; Liesbeth Vandenput; Fernand Labrie; Marie Lindersson; Ann-Christine Syvänen; Eric S Orwoll; Steven R Cummings; Joseph M Zmuda; Osten Ljunggren; Magnus K Karlsson; Dan Mellström; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.